176 related articles for article (PubMed ID: 15866483)
1. Agonist-induced activation releases peroxisome proliferator-activated receptor beta/delta from its inhibition by palmitate-induced nuclear factor-kappaB in skeletal muscle cells.
Jové M; Laguna JC; Vázquez-Carrera M
Biochim Biophys Acta; 2005 May; 1734(1):52-61. PubMed ID: 15866483
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
[TBL] [Abstract][Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
[TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
[TBL] [Abstract][Full Text] [Related]
5. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
Rodríguez-Calvo R; Serrano L; Coll T; Moullan N; Sánchez RM; Merlos M; Palomer X; Laguna JC; Michalik L; Wahli W; Vázquez-Carrera M
Diabetes; 2008 Aug; 57(8):2149-57. PubMed ID: 18443198
[TBL] [Abstract][Full Text] [Related]
6. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.
Alvarez-Guardia D; Palomer X; Coll T; Serrano L; Rodríguez-Calvo R; Davidson MM; Merlos M; El Kochairi I; Michalik L; Wahli W; Vázquez-Carrera M
Biochim Biophys Acta; 2011 Feb; 1811(2):59-67. PubMed ID: 21070867
[TBL] [Abstract][Full Text] [Related]
7. Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation.
Coll T; Jové M; Rodríguez-Calvo R; Eyre E; Palomer X; Sánchez RM; Merlos M; Laguna JC; Vázquez-Carrera M
Diabetes; 2006 Oct; 55(10):2779-87. PubMed ID: 17003343
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy.
Planavila A; Laguna JC; Vázquez-Carrera M
J Biol Chem; 2005 Apr; 280(17):17464-71. PubMed ID: 15728586
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin prevents peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) downregulation in lipopolysaccharide-stimulated H9c2 cells.
Planavila A; Sánchez RM; Merlos M; Laguna JC; Vázquez-Carrera M
Biochim Biophys Acta; 2005 Sep; 1736(2):120-7. PubMed ID: 16139565
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells.
Coll T; Palomer X; Blanco-Vaca F; Escolà-Gil JC; Sánchez RM; Laguna JC; Vázquez-Carrera M
Endocrinology; 2010 Feb; 151(2):537-48. PubMed ID: 20022932
[TBL] [Abstract][Full Text] [Related]
11. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
12. PPARβ/δ attenuates palmitate-induced endoplasmic reticulum stress and induces autophagic markers in human cardiac cells.
Palomer X; Capdevila-Busquets E; Botteri G; Salvadó L; Barroso E; Davidson MM; Michalik L; Wahli W; Vázquez-Carrera M
Int J Cardiol; 2014 Jun; 174(1):110-8. PubMed ID: 24767130
[TBL] [Abstract][Full Text] [Related]
13. PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism.
Salvadó L; Barroso E; Gómez-Foix AM; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetologia; 2014 Oct; 57(10):2126-35. PubMed ID: 25063273
[TBL] [Abstract][Full Text] [Related]
14. Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells.
Jové M; Planavila A; Laguna JC; Vázquez-Carrera M
Endocrinology; 2005 Jul; 146(7):3087-95. PubMed ID: 15802498
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
Pellieux C; Montessuit C; Papageorgiou I; Lerch R
Pflugers Arch; 2007 Dec; 455(3):443-54. PubMed ID: 17643263
[TBL] [Abstract][Full Text] [Related]
16. PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals.
Han S; Ritzenthaler JD; Zheng Y; Roman J
Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1238-49. PubMed ID: 18390835
[TBL] [Abstract][Full Text] [Related]
17. PPARβ/δ Agonism Upregulates Forkhead Box A2 to Reduce Inflammation in C2C12 Myoblasts and in Skeletal Muscle.
Phua WWT; Tan WR; Yip YS; Hew ID; Wee JWK; Cheng HS; Leow MKS; Wahli W; Tan NS
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143325
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
Meshkani R; Sadeghi A; Taheripak G; Zarghooni M; Gerayesh-Nejad S; Bakhtiyari S
Cell Biochem Funct; 2014 Dec; 32(8):683-91. PubMed ID: 25431031
[TBL] [Abstract][Full Text] [Related]
19. Lipid induced overexpression of NF-kappaB in skeletal muscle cells is linked to insulin resistance.
Barma P; Bhattacharya S; Bhattacharya A; Kundu R; Dasgupta S; Biswas A; Bhattacharya S; Roy SS; Bhattacharya S
Biochim Biophys Acta; 2009 Mar; 1792(3):190-200. PubMed ID: 19111928
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]